Globavir Biosciences, Inc.

📍 Los Altos, United States🗓 Founded 2011👥 3 employees💰 Last funded Dec 2019
Biotechnology Research🌐 globavir.com
Website LinkedIn
Globavir Biosciences is a San Francisco Bay Area based company committed to the development of therapeutics and diagnostics for the treatment of global infectious diseases. Globavir's development strategy harnesses the advantages offered by the 505(b)2 regulatory pathway, allowing for rapid development of new therapies. Globavir is initially focused on the treatment of dengue virus infection, a potentially lethal disease infecting 390 million patients annually. Through the combination of our proprietary diagnostic technology and advanced therapeutic candidates, Globavir is ideally positioned to rapidly impact the clinical landscape for Dengue patients. Globavir's platform discovery technologies have further identified candidate compounds with efficacy in additional viral indications, including West Nile, Japanese Encephalitis, Ebola, Marburg, and Hunta viruses.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Globavir Biosciences, Inc.?
Globavir Biosciences, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did Globavir Biosciences, Inc. last raise funding?
The most recent investment in Globavir Biosciences, Inc. recorded on gritt.io was in December 2019.
When was Globavir Biosciences, Inc. founded?
Globavir Biosciences, Inc. was founded in 2011.
What industry is Globavir Biosciences, Inc. in?
Globavir Biosciences, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Globavir Biosciences, Inc. based?
Globavir Biosciences, Inc. is headquartered in Los Altos, United States.